South Florida Enhanced Track

ACO Name and Location

Orange Accountable Care Organization of South Florida LLC
Previous Names: N/A
14750 NW 77th Court
Suite 308
Miami Lakes, FL 33016

 

ACO Primary Contact

Primary Contact Name Lissette Exposito RN, BSN, MHSA, Founder, President and CEO
Primary Contact Phone Number (786) 3638500
Primary Contact Email Address Lissette.Exposito@orangecaregroup.com

 

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture
ADVANCED MEDICAL CARE ASSOCIATES PA N
Ageless Medicine Associates Inc. N
ANA ELOSEGUI N
BERNARD WEINBACH MD PA N
BROWARD MEDICAL ASSOCIATES OF SOUTH FLORIDA N
CARDIOLOGY CONSULTANTS OF WEST BROWARD,PA N
CHANDRAKANT SHAH MD PA N
Charles Yanes, M.D., P.A. N
COOPER FAMILY MEDICAL PLLC N
EAST FLORIDA PREMIUM MEDICAL CARE LLC N
ELIAS A M FEANNY MD PA N
FARID MARQUEZ MD PA N
FRANCISCO ADELQUIS CRUZ MDPA N
GABRIEL M DESCHAMPS MD PA N
GERARDO QUINONEZ, M.D., P.A. N
GUS ARMENAKIS MD PA N
HECTOR M DELGADO D O P A N
IVAN ESPAILLAT MD PA N
JEFFREY GREIFF N
JEFFREY L PRESSER MD PA N
JOSE GONZALEZ N
LAWRENCE A BERGER MD PA N
LAZARO VIGOA MD PA N
LEVINSON AND CARDENAS, PA N
LILI ESTRIN MD, PA N
LUIS E DE ARMAS MD CORP N
MARTIN DAYTON DO PA N
MIAMI CENTER FOR ADVANCED CARDIOLOGY LLC N
MICHAEL D FELDMAN DO PA N
MICHAEL J BRAUN MD LLC N
Milton A. Jimenez MD PA N
MIREL SANCHEZ, M.D., P.A. N
MY PERSONAL MD, LLC N
OSCAR MENDEZ MD PA N
OTTO L SECADA MD PA N
PATRICIA BRAVO MD PA N
PAZ ALVAREZ LLC N
PEDRO G. ALVAREZ, D.O., P.A. N
PEDRO ORLANDO DIAZ MD PA N
QUALCARE MEDICAL GROUP INC N
ROBERTO URQUIZA M D P A N
ROMEO E ROJAS MD PA N
SOFFER HEART INSTITUTE PA N
SOHAIL DELFANI MD P.A. N
SOUTH FLORIDA INTERNISTS GROUP PA N
SUSSMAN & STALLER MD PA N
VINCENT C CHIN M.D., P.A. N

 

ACO governing body:

 

Member

Last Name

Member

First Name

Member

Title/Position

Member’s Voting Power: expressed as a percentage or number Membership Type ACO Participant Legal Business Name/DBA, if applicable
Exposito Lissette President, CEO & Board Chair 24% Board Chair and Voting Member
Quintela, MD Pablo CMIO & Board Member 0% Board Advisor
Weinbach, MD Bernard Medical Director & Board Member 18.75% ACO Participant & Voting Member BERNARD WEINBACH MD PA
Sanchez, MD Mirel Board Member 18.75% ACO Participant & Voting Member MIREL SANCHEZ, M.D., P.A.
Presser, MD Jeffrey Board Member 18.75% ACO Participant & Voting Member JEFFREY L PRESSER MD PA
Cooper, MD Catherine Board Member 18.75% ACO Participant & Voting Member COOPER FAMILY MEDICAL PLLC
Oliver Mara Board Member 1% ACO Patient and Medicare Beneficiary Representative

 

Key ACO clinical and administrative leadership:

  • ACO Executive: Lissette Exposito
  • Medical Director: Mirel Sanchez, MD
  • Compliance Officer: Marc Troisi
  • Quality Assurance/Improvement Officer: Pablo Quintela, MD

 

Associated committees and committee leadership:

 

Committee Name Committee Leader Name and Position
Quality and Informatics Pablo Quintela, MD, Chair
Patient Experience Raphael Ruiz, Chair
Finance and Contracting Frank Exposito, Co-Chair

Pablo Quintela, MD, Co-Chair

 

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Networks of individual practices of ACO professionals

 

Shared Savings and Losses

Amount of Shared Savings/Losses:

  • First Agreement Period
    • Performance Year 2020, $16,161,631
    • Performance Year 2019, $6,692,187
    • Performance Year 2018, $3,172,313
    • Performance Year 2017, $2,643,135

Shared Savings Distribution:

  • First Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: 20%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2019
      • Proportion invested in infrastructure: 20%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2018
      • Proportion invested in infrastructure: 20%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2017
      • Proportion invested in infrastructure: 20%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 60%

 

Quality Performance Results

2020 Quality Performance Results:

 

ACO # Measure Name Rate ACO Mean
ACO-8 [1] Risk Standardized, All Condition Readmission 15.94 15.38
ACO-38 [1,2] Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions 42.91 51.34
ACO-43 [3] Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) 0.76 1.69
ACO-13 Falls: Screening for Future Fall Risk 90.38 90.73
ACO-14 Preventive Care and Screening: Influenza Immunization 91.40 76.03
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 96.67 81.67
ACO-18 Preventive Care and Screening: Screening for Depression and Follow-up Plan 82.82 71.46
ACO-19 Colorectal Cancer Screening 85.20 72.59
ACO-20 Breast Cancer Screening 84.38 74.05
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 86.67 83.37
ACO-40 Depression Remission at Twelve Months 9.38 13.99
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 11.67 14.70
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 80.80 72.87

 

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

 

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR §425.612.

 

 

 

Didn’t find what you’re looking for?
Contact Us with questions, comments, and requests.